Research Article
Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs
Table 1
Patient baseline characteristics.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; FBG: fasting blood glucose; HbA1c: glycosylated hemoglobin; ALT: alanine aminotransferase; eGFR: estimated glomerular filtration rate; TC: total cholesterol; HOMA-beta: homeostasis model assessment for pancreatic beta-cell function; HOMA-CR: homeostasis model assessment of C-peptide secretion; DPP4: dipeptidase-4 inhibitor. |